Psychobiotics and Epigenetics: Reprogramming emotional pathways

Emerging evidence suggests that the gut–brain axis plays a central role in regulating mental health, with microbiota-derived signals modulating neurotransmission, immune activity, and even gene expression through epigenetic mechanisms. Psychobiotics, defined as probiotics and prebiotics that exert beneficial effects on the central nervous system, represent a frontier in biomedicine. This review explores the intersection of psychobiotics and epigenetics, focusing on their potential to modulate anxiety, depression, sleep disorders, and panic syndrome. We highlight recent mechanistic findings, including modulation of DNA methylation, histone acetylation, and microRNA expression, linking gut microbial metabolites to neural plasticity and stress response regulation. A comparative analysis of traditional pharmacological therapies versus psychobiotic interventions is presented, emphasizing efficacy, safety, and future translational opportunities. By integrating microbiome science, neuropsychiatry, and epigenetics, this work sheds light on innovative therapeutic strategies that may reshape modern psychiatry.